Long Grove Pharmaceuticals launches triamcinolone acetonide injectable suspension, USP, which is indicated for multiple conditions including the treatment of various types of arthritis. The FDA-approved generic is an AB-rated generic for Kenalog-40, is TAA compliant, and made in the European Union. It is available in single and multiple vial presentations and does not contain natural rubber latex. This launch is the first in a series of releases planned for the coming year. Long Grove Pharmaceuticals is a generics manufacturer focusing on complex generics, including injectables and topical products.